InterMed Gains Financial Leverage

DORTMUND, Germany—InterMed Discovery (IMD) announced the close of an equity transaction worth €7.44 million (US$9.85 million) by Biotropics Malaysia Berhad, which further solidifies the minority stake held by Biotropics in IMD. According to the companies, the funding will fuel further development of functional ingredients and pharmaceuticals, and provide Biotropics with access to the IMD database and technology to develop new ingredients.